EdgarLookup

James River Group Holdings, Inc. — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that James River Group Holdings, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
6.9%
Profit Margin
Net income ÷ revenue
1%
Return on Assets
Net income ÷ assets
7.78x
Debt-to-Equity
Total liabilities ÷ equity
-2.8%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $687.61M Mar 3, 2026
FY2025 Dec 31, 2024 $707.63M Mar 3, 2026
FY2023 Dec 31, 2023 $218.10M Feb 29, 2024
FY2023 Sep 30, 2023 $210.32M Feb 29, 2024
FY2023 Jun 30, 2023 $194.78M Feb 29, 2024
FY2023 Mar 31, 2023 $188.80M Feb 29, 2024
FY2023 Dec 31, 2022 $186.81M Feb 29, 2024
FY2023 Sep 30, 2022 $162.23M Feb 29, 2024
FY2023 Jun 30, 2022 $154.86M Feb 29, 2024
FY2023 Mar 31, 2022 $157.63M Feb 29, 2024

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $47.43M Mar 3, 2026
FY2025 Dec 31, 2024 ($81.12M) Mar 3, 2026
FY2023 Dec 31, 2023 ($150.16M) Feb 29, 2024
FY2023 Sep 30, 2023 $19.55M Feb 29, 2024
FY2023 Jun 30, 2023 $15.91M Feb 29, 2024
FY2023 Mar 31, 2023 $7.01M Feb 29, 2024
FY2023 Dec 31, 2022 $17.73M Feb 29, 2024
FY2023 Sep 30, 2022 ($4.62M) Feb 29, 2024
FY2023 Jun 30, 2022 $7.66M Feb 29, 2024
FY2023 Mar 31, 2022 $10.21M Feb 29, 2024

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($18.79M) Mar 3, 2026
FY2025 Dec 31, 2024 ($247.09M) Mar 3, 2026
FY2025 Dec 31, 2023 $87.95M Mar 3, 2026
FY2024 Dec 31, 2022 $222.73M Mar 4, 2025
FY2023 Dec 31, 2021 ($913.55M) Feb 29, 2024
FY2022 Dec 31, 2020 ($273.83M) Feb 28, 2023
FY2021 Dec 31, 2019 $1.49B Mar 1, 2022
FY2020 Dec 31, 2018 $290.03M Feb 26, 2021
FY2019 Dec 31, 2017 $207.82M Feb 27, 2020
FY2018 Dec 31, 2016 $154.35M Feb 27, 2019

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $4.80M Mar 3, 2026
FY2025 Dec 31, 2024 $4.89M Mar 3, 2026
FY2025 Dec 31, 2023 $6.43M Mar 3, 2026
FY2024 Dec 31, 2022 $8.22M Mar 4, 2025
FY2023 Dec 31, 2021 $6.30M Feb 29, 2024
FY2022 Dec 31, 2020 $549.0K Feb 28, 2023
FY2021 Dec 31, 2019 $519.0K Mar 1, 2022

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $4.86B Mar 3, 2026
FY2025 Dec 31, 2024 $5.01B Mar 3, 2026
FY2024 Dec 31, 2023 $5.32B Mar 4, 2025
FY2023 Dec 31, 2022 $5.14B Feb 29, 2024
FY2022 Dec 31, 2021 $4.95B Feb 28, 2023
FY2022 Dec 31, 2020 $5.06B Feb 28, 2023
FY2021 Dec 31, 2019 $5.02B Mar 1, 2022
FY2020 Dec 31, 2018 $3.14B Feb 26, 2021
FY2019 Dec 31, 2017 $2.76B Feb 27, 2020
FY2018 Dec 31, 2016 $2.35B Feb 27, 2019

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $4.19B Mar 3, 2026
FY2025 Dec 31, 2024 $4.41B Mar 3, 2026
FY2024 Dec 31, 2023 $4.64B Mar 4, 2025
FY2023 Dec 31, 2022 $4.44B Feb 29, 2024
FY2022 Dec 31, 2021 $4.22B Feb 28, 2023
FY2021 Dec 31, 2020 $4.27B Mar 1, 2022
FY2020 Dec 31, 2019 $4.25B Feb 26, 2021
FY2019 Dec 31, 2018 $2.43B Feb 27, 2020
FY2018 Dec 31, 2017 $2.06B Feb 27, 2019
FY2017 Dec 31, 2016 $1.65B Mar 1, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $538.15M Mar 3, 2026
FY2025 Dec 31, 2024 $460.92M Mar 3, 2026
FY2025 Dec 31, 2023 $534.62M Mar 3, 2026
FY2025 Dec 31, 2022 $553.77M Mar 3, 2026
FY2024 Dec 31, 2021 $725.36M Mar 4, 2025
FY2023 Dec 31, 2020 $795.61M Feb 29, 2024
FY2022 Dec 31, 2019 $778.58M Feb 28, 2023
FY2021 Dec 31, 2018 $709.24M Mar 1, 2022
FY2020 Dec 31, 2017 $694.70M Feb 26, 2021
FY2019 Dec 31, 2016 $693.22M Feb 27, 2020

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $181.83M Mar 3, 2026
FY2025 Dec 31, 2024 $181.83M Mar 3, 2026
FY2025 Dec 31, 2023 $181.83M Mar 3, 2026
FY2024 Dec 31, 2022 $181.83M Mar 4, 2025
FY2023 Dec 31, 2021 $181.83M Feb 29, 2024
FY2022 Dec 31, 2020 $181.83M Feb 28, 2023
FY2021 Dec 31, 2019 $181.83M Mar 1, 2022
FY2020 Dec 31, 2018 $181.83M Feb 26, 2021
FY2019 Dec 31, 2017 $181.83M Feb 27, 2020
FY2018 Dec 31, 2016 $181.83M Feb 27, 2019

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($364.73M) Mar 3, 2026
FY2025 Dec 31, 2024 ($402.41M) Mar 3, 2026
FY2024 Dec 31, 2023 ($277.91M) Mar 4, 2025
FY2023 Dec 31, 2022 ($152.06M) Feb 29, 2024
FY2022 Dec 31, 2021 ($166.66M) Feb 28, 2023
FY2021 Dec 31, 2020 $49.23M Mar 1, 2022
FY2020 Dec 31, 2019 $89.59M Feb 26, 2021
FY2019 Dec 31, 2018 $79.75M Feb 27, 2020
FY2018 Dec 31, 2017 $48.20M Feb 27, 2019
FY2017 Dec 31, 2016 $55.23M Mar 1, 2018

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $260.94M Mar 3, 2026
FY2025 Dec 31, 2024 $362.35M Mar 3, 2026
FY2024 Dec 31, 2023 $274.30M Mar 4, 2025
FY2023 Dec 31, 2022 $159.20M Feb 29, 2024
FY2022 Dec 31, 2021 $190.12M Feb 28, 2023
FY2021 Dec 31, 2020 $162.26M Mar 1, 2022
FY2020 Dec 31, 2019 $206.91M Feb 26, 2021
FY2019 Dec 31, 2018 $172.46M Feb 27, 2020
FY2018 Dec 31, 2017 $163.50M Feb 27, 2019
FY2018 Dec 31, 2016 $109.78M Feb 27, 2019

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2018 Dec 31, 2018 $118.30M Feb 27, 2019
FY2018 Dec 31, 2017 $98.30M Feb 27, 2019
FY2017 Dec 31, 2016 $88.30M Mar 1, 2018
FY2016 Dec 31, 2015 $88.30M Mar 10, 2017
FY2015 Dec 31, 2014 $88.30M Mar 10, 2016

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 0 Mar 3, 2026
FY2025 Dec 31, 2024 (3) Mar 3, 2026
FY2023 Dec 31, 2023 (4) Feb 29, 2024
FY2023 Sep 30, 2023 0 Feb 29, 2024
FY2023 Jun 30, 2023 0 Feb 29, 2024
FY2023 Mar 31, 2023 0 Feb 29, 2024
FY2023 Dec 31, 2022 0 Feb 29, 2024
FY2023 Sep 30, 2022 0 Feb 29, 2024
FY2023 Jun 30, 2022 0 Feb 29, 2024
FY2023 Mar 31, 2022 0 Feb 29, 2024

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 0 Mar 3, 2026
FY2025 Dec 31, 2024 (3) Mar 3, 2026
FY2023 Dec 31, 2023 (3) Feb 29, 2024
FY2023 Sep 30, 2023 0 Feb 29, 2024
FY2023 Jun 30, 2023 0 Feb 29, 2024
FY2023 Mar 31, 2023 0 Feb 29, 2024
FY2023 Dec 31, 2022 0 Feb 29, 2024
FY2023 Sep 30, 2022 0 Feb 29, 2024
FY2023 Jun 30, 2022 0 Feb 29, 2024
FY2023 Mar 31, 2022 0 Feb 29, 2024

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 45.97M Mar 3, 2026
FY2025 Dec 31, 2024 45.64M Mar 3, 2026
FY2024 Dec 31, 2023 37.64M Mar 4, 2025
FY2023 Dec 31, 2022 37.47M Feb 29, 2024
FY2022 Dec 31, 2021 37.37M Feb 28, 2023
FY2021 Dec 31, 2020 30.65M Mar 1, 2022
FY2020 Dec 31, 2019 30.42M Feb 26, 2021
FY2020 Dec 31, 2018 29.99M Feb 26, 2021
FY2019 Dec 31, 2017 29.70M Feb 27, 2020
FY2018 Dec 31, 2016 29.26M Feb 27, 2019

Dividends Paid

Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $2.00M Mar 3, 2026
FY2025 Dec 31, 2024 $6.23M Mar 3, 2026
FY2025 Dec 31, 2023 $7.75M Mar 3, 2026
FY2024 Dec 31, 2022 $7.80M Mar 4, 2025
FY2023 Dec 31, 2021 $43.24M Feb 29, 2024
FY2022 Dec 31, 2020 $37.05M Feb 28, 2023